Additional Metadata
Keywords B cell leukemia, B cell precursor acute lymphoblastic leukemia, CD147 antigen, Western blotting, acute lymphoblastic leukemia, basigin (CD147), cancer relapse, cell migration, cell proliferation, diagnosis-relapse, extramedullary, flow cytometry, gene expression profiling, gene rearrangement, human, immunoglobulin, immunophenotyping, letter, lymphocyte differentiation, messenger RNA, minimal residual disease, normal B cells, paediatric acute lymphoblastic leukaemia, pre B lymphocyte, priority journal, prognosis, protein expression, protein function, quantitative analysis, real time polymerase chain reaction, tumor marker
Persistent URL dx.doi.org/10.1111/j.1365-2141.2010.08240.x, hdl.handle.net/1765/20852
Citation
de Vries, J.F., te Marvelde, J.G., Wind, H.K., van Dongen, J.J.M., & van der Velden, V.H.J.. (2010). The potential use of basigin (CD147) as a prognostic marker in B-cell precursor acute lymphoblastic leukaemia. British Journal of Haematology, 150(5), 624–626. doi:10.1111/j.1365-2141.2010.08240.x